The 10 th amendment prohibits states, including California, from filing for bankruptcy. While defaults are technically ...

(Reuters) -Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.35 billion in ...

Ben Lerer, Lerer Hippeau managing director, joins 'Squawk on the Street' to discuss his outlook for the IPO market what's ...

Slide Insurance Holdings, Inc., the technology-enabled insurer, has launched its initial public offering (IPO) of 20,000,000 ...

Wakefit.co rebrands ahead of IPO, targets ₹1500-₹2000 crore valuation, achieves ₹1000 crore revenue, and plans product ...

When Chime CEO Chris Britt pitched his company to venture capitalists a decade ago, he got a lot of handshakes and little ...

Caris Life Sciences, which is backed by Sixth Street and JH Whitney, has filed for an IPO. Headquartered in Irving, Texas, Caris Life Sciences is a medical tech company. The IPO price is expected to ...

Insurance tech company Slide is aiming for a valuation of up to $2.12 billion in its U.S. initial public offering, joining a ...

Along with its Caris Assure liquid biopsy test for treatment selection and its MI Profile tumor tissue sequencing platform, ...

Slide Insurance Holdings, Inc. announced the launch of its initial public offering (IPO) of 20 million shares of common stock ...

Caris Life Sciences outlined plans for an initial public offering that could give the precision-medicine company a market capitalization topping $5 billion. Caris on Monday said it plans to sell more ...

Lenskart has converted to a public entity as it prepares for a potential $1-billion IPO, aiming for a $10 billion valuation.